Reject EU rules on private equity firms, CBI urges

Business leaders will today launch an 11th-hour bid to scupper parts of the controversial EU Alternative Investment Fund Managers Directive.

The Confederation of British Industry (CBI) is urging MEPs to vote down several provisions within the directive, which is aimed at private equity firms and hedge fund managers, warning that they could "harm companies that are already struggling with the economic downturn and harm employee relations".

The directive in its current form would force private equity-owned companies to disclose a swathe of what the CBI says is "commercially sensitive information" by mandating that private equity funds publish information about issues such as research and development (R&D) programmes, remuneration policies and other sensitive data on companies they own.

The business group is also concerned that plans to increase disclosure requirements on private equity-owned companies themselves are unclear and could result in widespread confusion.

The CBI further argues that the disclosure demands would "increase costs and bureaucracy, and prevent a level playing field because other privately owned companies would not be affected". It argues that they would have the effect of "stifling business innovation".

The CBI has also sounded the alarm about the directive's attempts to force improvements in private equity firms' dialogue with employees of the companies they own. It argues that private equity funds are no different to shareholders in quoted companies and that dialogue should remain between workers and management.

"Treating employees differently depending on the ownership of a company would set a dangerous precedent," the CBI is warning.

It will also raise particular concern about the impacts of proposed rules on small and medium-sized companies. Under the terms of the draft legislation, these could affect companies with as few as 50 staff, many of which rely on the private equity industry for funding at a time when bank financing has all but dried up.

The CBI said it welcomed a letter to MEPs signed by nearly 700 companies across Europe warning of the dangers of the AIFM legislation, and calling for all companies to be treated fairly. BusinesseEurope has expressed similar concerns.

John Cridland, the CBI's deputy director-general, said: "The proposed legislation would damage companies owned by private equity firms, and discourage investment. We are particularly concerned about the impact it would have on small and medium-sized companies.

"The additional bureaucracy and forced disclosure of commercially sensitive information would be a real problem, and impede companies that should be encouraged in order to foster economic recovery."

The CBI has long argued that private equity offers companies an important source of capital, which it said had become vital now that bank lending is constrained.

However, private equity firms have found themselves increasingly under fire in recent years amid sharp criticism of debt-financed buyouts of household name companies and the effect they have on employees.

Suggested Topics
Start your day with The Independent, sign up for daily news emails
News
election 2015The 10 best quotes of the campaign
News
A caravan being used as a polling station in Ford near Salisbury, during the 2010 election
election 2015The Independent's guide to get you through polling day
News
people
Voices
David Blunkett joins the Labour candidate for Redcar Anna Turley on a campaigning visit last month
voicesWhat I learnt from my years in government, by the former Home Secretary David Blunkett
ebooks
ebooksA celebration of British elections
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Ashdown Group: Editor-in-chief - Financial Services - City, London

£60000 - £70000 per annum + benefits : Ashdown Group: A highly successful, glo...

Ashdown Group: Junior Application Support Analyst - Fluent German Speaker

£25000 - £30000 per annum + benefits: Ashdown Group: A global leader operating...

Guru Careers: Management Accountant

£27 - 35k + Bonus + Benefits: Guru Careers: A Management Accountant is needed ...

Guru Careers: Project Manager / Business Analyst

£40-50k + Benefits.: Guru Careers: A Project Manager / Business Analyst is nee...

Day In a Page

General Election 2015: ‘We will not sit down with Nicola Sturgeon’, says Ed Balls

'We will not sit down with Nicola Sturgeon'

In an exclusive interview, Ed Balls says he won't negotiate his first Budget with SNP MPs - even if Labour need their votes to secure its passage
VE Day 70th anniversary: How ordinary Britons celebrated the end of war in Europe

How ordinary Britons celebrated VE Day

Our perception of VE Day usually involves crowds of giddy Britons casting off the shackles of war with gay abandon. The truth was more nuanced
They came in with William Caxton's printing press, but typefaces still matter in the digital age

Typefaces still matter in the digital age

A new typeface once took years to create, now thousands are available at the click of a drop-down menu. So why do most of us still rely on the old classics, asks Meg Carter?
Discovery of 'missing link' between the two main life-forms on Earth could explain evolution of animals, say scientists

'Missing link' between Earth's two life-forms found

New microbial species tells us something about our dark past, say scientists
The Pan Am Experience is a 'flight' back to the 1970s that never takes off - at least, not literally

Pan Am Experience: A 'flight' back to the 70s

Tim Walker checks in and checks out a four-hour journey with a difference
Humans aren't alone in indulging in politics - it's everywhere in the animal world

Humans aren't alone in indulging in politics

Voting, mutual back-scratching, coups and charismatic leaders - it's everywhere in the animal world
Crisp sales are in decline - but this tasty trivia might tempt back the turncoats

Crisp sales are in decline

As a nation we're filling up on popcorn and pitta chips and forsaking their potato-based predecessors
Ronald McDonald the muse? Why Banksy, Ron English and Keith Coventry are lovin' Maccy D's

Ronald McDonald the muse

A new wave of artists is taking inspiration from the fast food chain
13 best picnic blankets

13 best picnic blankets

Dine al fresco without the grass stains and damp bottoms with something from our pick of picnic rugs
Barcelona 3 Bayern Munich 0 player ratings: Lionel Messi scores twice - but does he score highest in our ratings?

Barcelona vs Bayern Munich player ratings

Lionel Messi scores twice - but does he score highest in our ratings?
Martin Guptill: Explosive New Zealand batsman who sets the range for Kiwis' big guns

Explosive batsman who sets the range for Kiwis' big guns

Martin Guptill has smashed early runs for Derbyshire and tells Richard Edwards to expect more from the 'freakish' Brendon McCullum and his buoyant team during their tour of England
General Election 2015: Ed Miliband's unlikely journey from hapless geek to heart-throb

Miliband's unlikely journey from hapless geek to heart-throb

He was meant to be Labour's biggest handicap - but has become almost an asset
General Election 2015: A guide to the smaller parties, from the the National Health Action Party to the Church of the Militant Elvis Party

On the margins

From Militant Elvis to Women's Equality: a guide to the underdogs standing in the election
Amr Darrag: Ex-Muslim Brotherhood minister in exile still believes Egypt's military regime can be replaced with 'moderate' Islamic rule

'This is the battle of young Egypt for the future of our country'

Ex-Muslim Brotherhood minister Amr Darrag still believes the opposition can rid Egypt of its military regime and replace it with 'moderate' Islamic rule, he tells Robert Fisk
Why patients must rely less on doctors: Improving our own health is the 'blockbuster drug of the century'

Why patients must rely less on doctors

Improving our own health is the 'blockbuster drug of the century'